{"disease":{"id":"who-grade-iii-or-iv-recurrent-glioma","name":"who grade iii or iv recurrent glioma"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT02278510","title":"Topotecan Using Convection-Enhanced Delivery (CED) in High Grade Glioma","phase":"EARLY_PHASE1","overall_status":"COMPLETED","enrollment_count":3,"lead_sponsor_name":"Michael Vogelbaum, MD, PhD","has_results":false}],"total":1},"guidelines":[],"source":"Drug Landscape verified database"}